Skip to product information
1 of 1

GeneBio Systems

Recombinant Human Activin Receptor 2B/ACVR2B Protein (Fc & His Tag)

Recombinant Human Activin Receptor 2B/ACVR2B Protein (Fc & His Tag)

SKU:PKSH032041

Regular price £137.00 GBP
Regular price Sale price £137.00 GBP
Sale Sold out
Shipping calculated at checkout.

Size: 50μg

Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Shipping: This product is provided as lyophilized powder which is shipped with ice packs.

Exp date: 12 months

Category ID_II: Recombinant Proteins

Category ID_III: Others

Abbreviation: Activin Receptor 2B;ACVR2B

Target Synonym: ACTR-IIB;ACVR2B;Activin Receptor Type IIB;Activin Receptor Type-2B;BMP Type II Receptor;BMP Type-2 Receptor;BMPR-3;Bone Morphogenetic Protein Receptor Type II;Bone Morphogenetic Protein Receptor Type-2

Research Areas: Signal Transduction;Stem cells

Conjugation:

Target Species: Human

Expression Host: HEK293 Cells

Application:

Fusion tag: C-Fc-His

UNIProt ID: Q13705

Accession: Q13705

Background: Activin proteins that belong to the transforming growth factor-beta (TGF-β) superfamily; exert their biological actions by binding to heteromeric receptor complexes of type I and type II serine/threonine kinase receptors. On ligand binding; type I and II receptors form a stable complex; resulting in phosphorylation of type I receptors by type II receptors with constitutive kinase activity; and subsequently initiates the activation of downstream molecules including the endogenous Smads. ActRIIB; also known as ActRIIB; is a type II receptor containing an extracellular domain (ECD); a transmembrane segment; and a cytoplasmic region that includes the kinase domain. ActRIIB is a receptor for activin A; activin B and inhibin A. Multiple ActRIIB isoforms can also be generated; which bind activin isoforms with different affinities.

Concentration:

Activity: Not validated for activity

Sequence: Ser19-Thr134

Purity: > 95 % as determined by reducing SDS-PAGE.

Formulation: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.

Reconstitution: Please refer to the printed manual for detailed information.

Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.

Calculated MW: 41.3 kDa

ObservedMW: 60 kDa

View full details